Free Trial
ASX:DNA

Donaco International (DNA) Stock Price, News & Analysis

Donaco International logo

About Donaco International Stock (ASX:DNA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
657,200 shs
Average Volume
N/A
Market Capitalization
A$35.79 million
P/E Ratio
0.90
Dividend Yield
2.86%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Donaco International and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DNA Stock News Headlines

Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
See More Headlines

DNA Stock Analysis - Frequently Asked Questions

Donaco International Limited (ASX:DNA) issued its quarterly earnings results on Thursday, February, 28th. The company reported ($0.05) earnings per share (EPS) for the quarter. Donaco International had a net margin of 81.03% and a trailing twelve-month return on equity of 29.02%.

Company Calendar

Last Earnings
2/28/2019
Today
9/13/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Resorts & Casinos
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:DNA
CIK
N/A
Fax
N/A
Employees
640
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.03
Trailing P/E Ratio
0.90
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$37.06 million
Net Margins
81.03%
Pretax Margin
N/A
Return on Equity
29.02%
Return on Assets
5.12%

Debt

Debt-to-Equity Ratio
15.27
Current Ratio
0.77
Quick Ratio
0.18

Sales & Book Value

Annual Sales
A$39.53 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.23
Book Value
A$0.12 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,230,000,000
Free Float
N/A
Market Cap
A$35.79 million
Optionable
Not Optionable
Beta
1.20
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (ASX:DNA) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners